Nabil Adra

Hematology | Oncology

535 Barnhill Dr
Ste 242a
Indianapolis, IN 46202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 105 publications

NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026.

NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: May 14, 2026

How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer.

How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 14, 2026

Evaluating Circulating DNA as a Prognostic Biomarker in Bladder Cancer Subtypes: A Preliminary Short Report.

Evaluating Circulating DNA as a Prognostic Biomarker in Bladder Cancer Subtypes: A Preliminary Short Report.

Journal: Clinical genitourinary cancer

Published: May 09, 2026

Primary Mediastinal Seminoma: Clinical Characteristics and Outcomes.

Primary Mediastinal Seminoma: Clinical Characteristics and Outcomes.

Journal: Clinical genitourinary cancer

Published: March 17, 2026

Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

Journal: JCO precision oncology

Published: March 02, 2026

International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions: Working Group 4 Precursor Lesions of Testis Results of a Premeeting Survey.

International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions: Working Group 4 Precursor Lesions of Testis Results of a Premeeting Survey.

Journal: The American journal of surgical pathology

Published: February 22, 2026

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.

Journal: The New England journal of medicine

Published: February 18, 2026

Quantitative Assessment of Seminoma in the Testicle Among Nonseminomatous Germ Cell Tumor Patients on Operative Difficulty, Morbidity and Pathological Outcomes at Postchemotherapy RPLND.

Quantitative Assessment of Seminoma in the Testicle Among Nonseminomatous Germ Cell Tumor Patients on Operative Difficulty, Morbidity and Pathological Outcomes at Postchemotherapy RPLND.

Journal: Clinical genitourinary cancer

Published: November 15, 2025

Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.

Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 10, 2025

Clinical stage IIA/B embryonal carcinoma predominant nonseminomatous germ cell tumor: Minimizing treatment burden.

Clinical stage IIA/B embryonal carcinoma predominant nonseminomatous germ cell tumor: Minimizing treatment burden.

Journal: Urologic oncology

Published: November 06, 2025

Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

Journal: JCO precision oncology

Published: September 24, 2025

Circulating cell-free DNA profiling reveals ancestry-dependent genetic variation in metastatic prostate cancer.

Circulating cell-free DNA profiling reveals ancestry-dependent genetic variation in metastatic prostate cancer.

Journal: Molecular biomedicine

Published: July 15, 2025

Showing 1-12 of 105

Last Updated: 09/26/2026